These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 18923023)

  • 1. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
    Nishi A; Kuroiwa M; Miller DB; O'Callaghan JP; Bateup HS; Shuto T; Sotogaku N; Fukuda T; Heintz N; Greengard P; Snyder GL
    J Neurosci; 2008 Oct; 28(42):10460-71. PubMed ID: 18923023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: biochemical and behavioral profiles of phosphodiesterase inhibition in dopaminergic neurotransmission.
    Nishi A; Snyder GL
    J Pharmacol Sci; 2010; 114(1):6-16. PubMed ID: 20716858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.
    Kuroiwa M; Snyder GL; Shuto T; Fukuda A; Yanagawa Y; Benavides DR; Nairn AC; Bibb JA; Greengard P; Nishi A
    Psychopharmacology (Berl); 2012 Feb; 219(4):1065-79. PubMed ID: 21833500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
    Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
    Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
    Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.
    Sahin B; Galdi S; Hendrick J; Greene RW; Snyder GL; Bibb JA
    Brain Res; 2007 Jan; 1129(1):1-14. PubMed ID: 17157277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons.
    Dell'anno MT; Pallottino S; Fisone G
    Neuropharmacology; 2013 Mar; 66():179-86. PubMed ID: 22507666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.
    Russwurm C; Koesling D; Russwurm M
    J Biol Chem; 2015 May; 290(19):11936-47. PubMed ID: 25762721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
    Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
    Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.
    Threlfell S; Sammut S; Menniti FS; Schmidt CJ; West AR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):785-95. PubMed ID: 19056933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
    Chini CC; Grande JP; Chini EN; Dousa TP
    J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of dopamine signaling in the striatum by phosphodiesterase inhibitors: novel therapeutics to treat neurological and psychiatric disorders.
    Ramirez AD; Smith SM
    Cent Nerv Syst Agents Med Chem; 2014; 14(2):72-82. PubMed ID: 25540976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-32.
    Polito M; Guiot E; Gangarossa G; Longueville S; Doulazmi M; Valjent E; Hervé D; Girault JA; Paupardin-Tritsch D; Castro LR; Vincent P
    eNeuro; 2015; 2(4):. PubMed ID: 26465004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal neurones have a specific ability to respond to phasic dopamine release.
    Castro LR; Brito M; Guiot E; Polito M; Korn CW; Hervé D; Girault JA; Paupardin-Tritsch D; Vincent P
    J Physiol; 2013 Jul; 591(13):3197-214. PubMed ID: 23551948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
    Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A
    J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PDE10A inhibitor, papaverine, differentially activates ERK in male and female rat striatal slices.
    Hsu YT; Liao G; Bi X; Oka T; Tamura S; Baudry M
    Neuropharmacology; 2011 Dec; 61(8):1275-81. PubMed ID: 21816164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum.
    Kuroiwa M; Bateup HS; Shuto T; Higashi H; Tanaka M; Nishi A
    J Neurochem; 2008 Nov; 107(4):1014-26. PubMed ID: 18823371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
    Borgkvist A; Usiello A; Greengard P; Fisone G
    Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
    Padovan-Neto FE; Sammut S; Chakroborty S; Dec AM; Threlfell S; Campbell PW; Mudrakola V; Harms JF; Schmidt CJ; West AR
    J Neurosci; 2015 Apr; 35(14):5781-91. PubMed ID: 25855188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.